case series:Camrelizumab Combined With Apatinib

A Single-arm, Open, Phase II Trial for Camrelizumab Injection Combined With Apatinib in the Treatment of Advanced or Recurrent Endometrial Carcinoma Patient Who Was Failure in First-line or Above Therapy

A multicenter, single-arm, exploratory clinical study to evaluate the safety and efficacy of camrelizumab combined with apatinib in neoadjuvant treatment of refractory HCC and adjuvant treatment of patients at risk of recurrence